|
|
|
|
pmid:
|
Murugesan V et al. |
Glucosylsphingosine is a key biomarker of Gaucher disease. |
2016 |
Am. J. Hematol. |
pmid:27441734
|
Franco M et al. |
Effect of velaglucerase alfa enzyme replacement therapy on red blood cell properties in Gaucher disease. |
2017 |
Am. J. Hematol. |
pmid:28621801
|
Zhang CK et al. |
Genome-wide association study of N370S homozygous Gaucher disease reveals the candidacy of CLN8 gene as a genetic modifier contributing to extreme phenotypic variation. |
2012 |
Am. J. Hematol. |
pmid:22388998
|
Atsumi S et al. |
Accumulation of tissue glucosylsphingosine in Gaucher-like mouse induced by the glucosylceramidase inhibitor cyclophellitol. |
1993 |
Arch. Biochem. Biophys. |
pmid:8323295
|
Legler G and Bieberich E |
Isolation of a cytosolic beta-glucosidase from calf liver and characterization of its active site with alkyl glucosides and basic glycosyl derivatives. |
1988 |
Arch. Biochem. Biophys. |
pmid:2963589
|
Lloyd-Evans E et al. |
Lyso-glycosphingolipids mobilize calcium from brain microsomes via multiple mechanisms. |
2003 |
Biochem. J. |
pmid:12917012
|
Gopalan V et al. |
Kinetic analysis of the interaction of alkyl glycosides with two human beta-glucosidases. |
1989 |
Biochem. J. |
pmid:2508630
|
Meivar-Levy I et al. |
Analysis of glucocerebrosidase activity using N-(1-[14C]hexanoyl)-D-erythroglucosylsphingosine demonstrates a correlation between levels of residual enzyme activity and the type of Gaucher disease. |
1994 |
Biochem. J. |
pmid:7980395
|
Dekker N et al. |
Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response. |
2011 |
Blood |
pmid:21868580
|
Mirzaian M et al. |
Mass spectrometric quantification of glucosylsphingosine in plasma and urine of type 1 Gaucher patients using an isotope standard. |
2015 |
Blood Cells Mol. Dis. |
pmid:25842368
|
Bischoff A et al. |
Lysosphingolipid receptor-mediated diuresis and natriuresis in anaesthetized rats. |
2001 |
Br. J. Pharmacol. |
pmid:11309265
|
Bischoff A et al. |
Sphingosine-1-phosphate and sphingosylphosphorylcholine constrict renal and mesenteric microvessels in vitro. |
2000 |
Br. J. Pharmacol. |
pmid:10952677
|
Bischoff A et al. |
Sphingosine-1-phosphate reduces rat renal and mesenteric blood flow in vivo in a pertussis toxin-sensitive manner. |
2000 |
Br. J. Pharmacol. |
pmid:10952678
|
Angka L et al. |
Glucopsychosine increases cytosolic calcium to induce calpain-mediated apoptosis of acute myeloid leukemia cells. |
2014 |
Cancer Lett. |
pmid:24631520
|
Zehavi U |
Synthesis of potentially caged sphingolipids, possible precursors of cellular modulators and second messengers. |
1997 |
Chem. Phys. Lipids |
pmid:9450322
|
Fuller M et al. |
Rapid, single-phase extraction of glucosylsphingosine from plasma: A universal screening and monitoring tool. |
2015 |
Clin. Chim. Acta |
pmid:26232157
|
Auray-Blais C et al. |
How well does urinary lyso-Gb3 function as a biomarker in Fabry disease? |
2010 |
Clin. Chim. Acta |
pmid:20716442
|
Nilsson O et al. |
Glycosphingolipid studies of visceral tissues and brain from type 1 Gaucher disease variants. |
1985 |
Clin. Genet. |
pmid:3924448
|
Dasgupta N et al. |
Neuronopathic Gaucher disease: dysregulated mRNAs and miRNAs in brain pathogenesis and effects of pharmacologic chaperone treatment in a mouse model. |
2015 |
Hum. Mol. Genet. |
pmid:26420838
|